Exercise for Weight Loss
(WAX Trial)
Trial Summary
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on medications that affect lipid or glucose metabolism, or if you take anti-coagulant medications.
Research shows that exercise, including moderate-intensity continuous training (MICT), can help reduce epicardial adipose tissue (a type of fat around the heart) and support cardiovascular health in people with overweight or obesity. While exercise alone often leads to modest weight loss, combining it with dietary changes can enhance weight loss results.
12345Research on moderate-intensity continuous training (MICT) generally shows it is safe for humans, including those who are overweight or obese. Studies have focused on its effects on heart health and weight loss, and no significant safety concerns have been reported.
26789The MICT exercise treatment involves moderate-intensity continuous training, which is different from high-intensity interval training (HIIT) that is often used for weight loss. MICT is a steady, moderate effort over a longer period, which may be easier for some people to maintain compared to the intense bursts of activity in HIIT.
210111213Eligibility Criteria
This trial is for premenopausal women aged 18-40 with a BMI of 30-40, who have stable weight and don't regularly exercise. It's not for those pregnant, lactating, with heart disease or metabolic diseases like diabetes, on certain medications affecting metabolism, using tobacco products, or with allergies to specific drugs.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
10% Weight Loss
Participants undergo a 10% weight loss program with or without exercise training, depending on group randomization. Metabolic tests are conducted before, at midpoint, and after the weight loss program.
Follow-up
Participants are monitored for safety and effectiveness after treatment. Follow-up testing is conducted at 2-, 4-, and 6-months post-weight loss.